Recent Finacing
Recent Raise
NH TherAguix is a French nanomedicine company developing AGuIX, an IV nanoparticle combining tumor targeting, MRI contrast, and radiosensitization, in clinical trials for brain metastases and cervical cancer.
Focus Areas
Recent Investors
Total Raised
Funding round
Investors
See the team members at NH TherAguix.
